1/2/2024 0 Comments Clobetasol topicalBJD (c) 2011 British Association of Dermatologists.Ĭlobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial. The facial lesions responded faster than the nonfacial ones. CONCLUSIONS: Both CP 0.05% and T 0.1% ointments offer similar benefit in paediatric vitiligo, both facial and nonfacial. OBJECTIVES: To assess efficacy and safety of these two therapies compared with each other and with placebo. BACKGROUND: Both clobetasol propionate 0.05% (CP 0.05%) and tacrolimus 0.1% (T 0.1%) ointments have been shown to be efficacious and safe in treating vitiligo in the paediatric population. clobetasol propionate 0.05% in childhood vitiligo. CONCLUSION: The present study proved the efficacy of twice-daily tacrolimus andĪ double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. OBJECTIVE: To compare the efficacy and safety of a high- vs low-potency topicalĪ comparative study in efficacy and safety of 0.1% tacrolimus and 0.05%Ĭlobetasol propionate ointment in discoid lupus erythematosus by modifiedĬutaneous lupus erythematosus disease area and severity index. IMPORTANCE: Alopecia areata is an idiopathic cause of hair loss with limited NEWS HIGHLIGHTS Published Studies Related to Clobetasol (Clobetasol Topical)Ĭlobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata inĬhildren: a randomized clinical trial. See all Clobetasol indications & dosage > Use in children under 12 years of age is not recommended. In a controlled pharmacokinetic study, some subjects experienced reversible suppression of the adrenals following 14 days of clobetasol propionate foam, 0.05% therapy (See Treatment beyond 2 consecutive weeks is not recommended and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis. Clobetasol, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight degree of mineralocorticoid activity.Ĭlobetasol propionate foam, 0.05% is a super-potent topical corticosteroid indicated for short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid- responsive dermatoses of the scalp, and for short-term topical treatment of mild to moderate plaque-type psoriasis on non-scalp regions excluding the face and intertriginous areas. Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage, Contraindications, Other Rx Info User Ratings / Reviews Side Effect ReportsĬlobetasol propionate foam, 0.05% contains clobetasol propionate, USP, a synthetic corticosteroid, for topical dermatologic use. Rx drug information, pharmaceutical research, clinical trials, news, and moreĬlobetasol (Clobetasol Propionate Topical) - Summary Clobetasol (Clobetasol Topical) - Drug Info, User Reviews, Side Effects, Research, Clinical Trials
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |